IMPORTANCE OF MARKERS OF THE PROLIFERATION AND APOPTOSIS FOR OVARIAN BODERLINE TUMOURS

For today, one of actual problems in gynecologic pathology are borderline tumours of the ovary to which frame of a case rate the high specific gravity is compounded by women of reproductive age. Thereupon often there is a question about safety treatment methods, that dictates necessity of an assessment of risk of development of recurrence of disease. In present article attempt to define prognostic importance of markers of proliferative activity (ki67, cyclin D1, p21), and pro-and antiapoptotic markers (p53, bax, bcl-2, survivin) for definition potentially an aggressive behavior of ovarian borderline tumour.